[Form 3] PDD Holdings Inc. Initial Statement of Beneficial Ownership
PDD Holdings Co-CEO Zhao Jiazhen filed an initial ownership report showing multiple option grants over the company’s ADSs.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PDD Holdings Co-CEO Zhao Jiazhen filed an initial ownership report showing multiple option grants over the company’s ADSs. Each option gives the right to receive one ADS at an exercise price of US$0.026, and each ADS represents four Class A ordinary shares.
Some option grants are already exercisable, while others vest in stages from 2026 through 2031, with expiration dates ranging from 2036 to 2044. Zhao also directly holds a small number of ADSs in addition to these option awards.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | ADSs | -- | -- | -- |
Footnotes (11)
- F1. Each American depositary share ("ADS") of the Issuer represents four (4) Class A ordinary shares.
- F2. These options are all exercisable as of the filing date. The expiration dates for 196,281 options, 200,000 options, 150,000 options, 112,500 options, 31,250 options and 37,500 options are August 31, 2036, February 28, 2037, August 31, 2038, August 31, 2039, March 31, 2041 and September 30, 2041, respectively.
- F3. Each option represents the right to receive, at settlement after exercise, one American Depositary Share ("ADS") of the Issuer, and has an exercise price of US$0.026.
- F4. These options will become exercisable on September 1, 2026. The expiration date for these options is August 31, 2039. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options.
- F5. One-third of these options will become exercisable on each of the following dates: April 1, 2026, April 1, 2027 and April 1, 2028. The expiration date for these options is March 31, 2041. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options.
- F6. One-third of these options will become exercisable on each of the following dates: October 1, 2026, October 1, 2027 and October 1, 2028. The expiration date for these options is September 30, 2041. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options.
- F7. One-fourth of these options will become exercisable on each of the following dates: April 1, 2026, April 1, 2027, April 1, 2028 and April 1, 2029. The expiration date for these options is March 31, 2042. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options.
- F8. One-fourth of these options will become exercisable on each of the following dates: October 1, 2026, October 1, 2027, October 1, 2028 and October 1, 2029. The expiration date for these options is September 30, 2042. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options.
- F9. One-fourth of these options will become exercisable on each of the following dates: May 1, 2027, May 1, 2028, May 1, 2029 and May 1, 2030. The expiration date for these options is April 30, 2043. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options.
- F10. One-fourth of these options will become exercisable on each of the following dates: December 1, 2027, December 1, 2028, December 1, 2029 and December 1, 2030. The expiration date for these options is November 30, 2043. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options.
- F11. One-fourth of these options will become exercisable on each of the following dates: May 1, 2028, May 1, 2029, May 1, 2030 and May 1, 2031. The expiration date for these options is April 30, 2044. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options.
AI-generated analysis. How Rhea-AI works. Not financial advice.
